BURLANDO, MARTINA
 Distribuzione geografica
Continente #
EU - Europa 5.546
Totale 5.546
Nazione #
IT - Italia 5.546
Totale 5.546
Città #
Genova 3.044
Genoa 1.023
Vado Ligure 781
Rapallo 672
Bordighera 26
Totale 5.546
Nome #
Le cheratosi attiniche nei pazienti con trombocitemia in trattamento con idrossiurea; L'esperienza della clinica dermatologica nella gestione dei farmaci biologici nella psoriasi moderata grave; Angiosarcoma della mammella. 261
Adverse effects of biological agents in the treatment of psoriasis. 146
TNF-α gene polymorphisms: association with disease susceptibility and response to anti-TNF-α treatment in psoriatic arthritis 143
Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets 138
Latent tuberculosis infection in patients with chronic plaque psoriasis: Evidence from the Italian Psocare Registry 133
Bilateral Warthin tumor in psoriatic patients in therapy with multiple immunosuppressive therapy 131
Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects 122
Different Responses to Ustekinumab of Two HLA-Cw6-positive Homozygous Twins with Psoriasis 119
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: Evidence from the Italian Psocare Registry 107
Psoriasis as a cardiovascular risk factor: Updates and algorithmic approach 103
Generalized annular granuloma associated with crowned dens syndrome, which resolved with colchicine treatment 102
Atopic-like dermatitis after secukinumab injection: A case report 102
PSOdisk is a reliable, intuitive instrument for the evaluation of psychological distress, which strongly correlates with DLQI: a preliminary study 100
Essential Thrombocythemia: The Dermatologic Point of View 96
Un cas de cryptococcose cutanèe primitive sans diffusion systemique chez un patient immunodeprimé 94
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study 87
Papular elastolytic giant cell granuloma: report of a case associated with monoclonal gammopathy and responsive to topical tacrolimus. 86
Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: Results from the Italian Psocare Registry 85
Active pharmacovigilance program in patients affected by psoriasis and inflammatory bowel diseases
 85
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience 84
Pruritus characteristics in a large Italian cohort of psoriatic patients 84
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study 83
Cutaneous drug eruption with an interface dermatitis pattern due to anti-tumour necrosis factor-alpha agents: A relevant class-effect 83
Autoantibody Profile of a Cohort of 78 Italian Patients with Mucous Membrane Pemphigoid: Correlation Between Reactivity Profile and Clinical Involvement 82
Could Terra firma-forme dermatosis induce eczematous halo dermatitis? An hypothesis 78
Comedonal variant of chronic cutaneous lupus erythematosus causing mutilation of the earlobe 77
The management of Autoimmune diseases in preconception, pregnancy and lactation 76
Biological therapy in genital psoriasis in women 76
Switching from Secukinumab to Ustekinumab in Psoriasis Patients: Results from a Multicenter Experience 75
Detection of antibodies to anti-TNF agents in psoriatic patients: a preliminary study. 74
Narrow-band imaging: a useful tool for early recognition of oral lichen planus malignant transformation? 72
Ciprofloxacin as a Trigger for Bullous Pemphigoid: The Second Case in the Literature 68
The quality of life in Italian psoriatic patients treated with biological drugs. 65
Primary cutaneous melanoma: Correlation between clinical and histologic aspects in a retrospective Italian study 65
Vasculitis associated with connective tissue diseases 64
An unusual case of bullous haemorrhagic vasculitis in a COVID-19 patient 64
Role of high-resolution ultrasound in the evaluation of psoriatic onychopathy 64
Atypical and Rare Forms of Cutaneous Lupus Erythematosus: The Importance of the Diagnosis for the Best Management of Patients 62
The STRIPP questionnaire (Screening Tool for Rheumatologic Investigation in Psoriatic Patients) as a new tool for the diagnosis of early psoriatic arthritis 61
Erythema multiforme after initiation of anti interleukin-12/23 (ustekinumab) treatment for plaque psoriasis 61
Acetazolamide: a new trigger for bullous pemphigoid? 61
Cutaneous effects of antihypertensive drugs 60
Cutaneous manifestations of hematologic malignancies the experience of an Italian dermatology department 60
Serial biologic therapies in psoriasis patients: A 12-year, single-center, retrospective observational study 57
The HLA-Cw6 Dilemma: Is It Really an Outcome Predictor in Psoriasis Patients under Biologic Therapy? A Monocentric Retrospective Analysis 56
Ashy dermatosis-like hyperpigmentation: not always the omeprazole's fault 55
Erythematous Maculopapular Eruption Induced by Anastrozole: The First Case 54
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study 53
A survey of psoriasis patients on biologics during COVID-19: a single centre experience 52
Study of efficacy and safety of rucinol and sophora alpha in the topical treatment of cutaneous hypermelanoses 51
COVID-19 “second wave” and vaccines: the dermatologists’ perspective 49
Effects of TNF-α inhibitors in patients with psoriasis and metabolic syndrome: a preliminary study 48
Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study 47
Cutaneous manifestations of HAV, HBV, HCV 46
Inflammatory/infectious cutaneous side effects of biological drugs in patients with psoriasis: a general review with personal data 46
Acute urticarial rash after covid-19 vaccination containing polysorbate 80 45
Usefulness of Dermoscopy in Eruptive Syringomas in an Elderly Woman 43
Consensus on the place in therapy of TNF-α inhibitors in the treatment of patients with chronic plaque psoriasis 43
Can Methotrexate be a successful treatment for unresponsive generalized annular elastolytic giant cell granuloma? Case report and review of the literature 43
Differenti risposte a Ustekinumab in due gemelli omozigoti HLA-CW6 positivi affetti da psoriasi 42
Considerations on inhibition of IL-23 in psoriatic women of childbearing potential 42
Linear atrophoderma of Moulin and atrophoderma of Pasini and Pierini. The relevance of ultrasound imaging in the initial assessment 41
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy 40
The 30th birthday of chronic ulcerative stomatitis: A systematic review 40
Bulky Condyloma Acuminata following Ustekinumab Treatment for Plaque Psoriasis: A Case Report 39
Guselkumab-associated bullous pemphigoid in a psoriasis patient: A case report and review of the literature 39
Cutaneous reactions to COVID-19 vaccine at the dermatology primary care 38
Reticular Erythematous Mucinosis: Exclusive Involvement of the Axillary Region 36
Cutaneous reactions to COVID-19 vaccine at the dermatology primary care 36
Six months into the pandemic. A review of skin manifestations in SARS-CoV-2 infection 35
A purplish plaque and multiple nodules on the arm 34
"De Novo" Psoriasis and Relapse of Psoriasis Induced by Dupilumab: Three New Cases and Review of the Literature 34
Institution of an interdisciplinary IBD centre is associated with improved healthcare utilisation 34
Lichen planus flare following COVID-19 vaccination: A case report 34
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review 34
Deferred time of delivery of biologic therapies in patients with stabilized psoriasis leads to a 'perceived satisfaction': a multicentric study 32
Crushed corticosteroid tablets in peristomal pyoderma gangrenosum: A case report 29
Increased serum level of N-terminal Pro-B-type natriuretic peptide in psoriatic patients: a single-center study 26
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study 24
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study 23
Dermatoscopically narrowed surgical margins for head and neck basal cell carcinoma: A retrospective case-control study 22
Dermatoskopisch kontrollierte, schmalere Resektionsränder bei Basalzellkarzinomen an Kopf und Hals: Retrospektive Fallkontrollstudie 20
Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients 20
Italian expert-based recommendations on the use of photo(chemo)therapy in the management of mycosis fungoides: Results of an e-Delphi consensus 20
Pruritic erythematous macules in a patient with systemic sarcoidosis: A quiz 19
Epstein-Barr virus reactivation after COVID-19 vaccination in a young immunocompetent man: a case report 18
Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting 16
Dimethyl fumarate-associated ashy dermatosis 15
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study 15
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS) 14
Early predictors of psoriatic arthritis: a Delphi-based consensus from Italian dermatology centers 13
Psoriasis patients' characteristics associated with high PASI response to tildrakizumab: an international dual center study 12
Severe Generalized Pustular Psoriasis Successfully Treated with Ixekizumab: A Case Report 12
Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis) 12
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient Wellbeing 11
Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study 10
Consensus on the place in therapy of biologics in the treatment of patients with chronic plaque psoriasis 10
Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study 9
Does psoriasis influence female sexual dysfunction? A multicentric Italian case-control study 9
Four-years experience with the preferential derivation care model for multidisciplinary care in patients with psoriasis and psoriatic arthritis 8
Totale 5.744
Categoria #
all - tutte 26.359
article - articoli 25.446
book - libri 0
conference - conferenze 913
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.718


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020883 0 0 0 0 0 119 180 78 113 216 150 27
2020/2021596 45 27 51 29 90 60 17 62 43 97 42 33
2021/2022869 34 31 28 75 36 120 12 186 86 110 25 126
2022/2023823 79 68 16 77 110 114 9 51 172 15 101 11
2023/2024906 33 76 38 103 67 149 56 118 18 59 110 79
2024/2025847 70 137 48 136 263 193 0 0 0 0 0 0
Totale 5.744